The company was successfully shifting more products directly into China and, as a result, ATM had generated higher margins than expected.
''The strong result is all the more positive, given higher losses in the United Kingdom and United States than expected. The fresh milk strategy in Australia had reached a plateau with mainstream retailers.
However, 4% sales growth was achieved as sales with emerging retailers increased,'' he said.
ATM markets milk based on the supposed health benefits of the A2 milk protein
The reported profit was $30.4million in the 12 months ended June 30, from a loss of $2.1million a year earlier. Sales climbed to $352.8million, within its guidance range, from $154.8million a year earlier.
The company sank into the red in the previous year as it invested in offshore expansion to drive sales of its A2 Platinum infant formula.
The shares dipped to a six-month low in June, amid concerns about increased food safety rules in China and the emergence of rivals in the Australian market selling milk based on the same A2 milk protein claims.
Mr Foster said the Australia and New Zealand business achieved good growth in infant formula sales, as expected. Revenue was not disclosed separated but he estimated it to be about $178million compared with $37million in the previous corresponding period.
The company achieved ''outstanding'' results in China and Asia, driven by larger quantities being sold into China.
ATM had continued its strong investment theme in the US and UK with a operating loss of $20.5million versus a forecast loss of $18.6million.
Sales were well ahead of expectations, suggesting more penetration in the US or UK than expected and more investment in those markets than expected, Mr Foster said.
A2 did not provide the market with any guidance for 2017.
Commentary suggested the company expected continued strong growth from infant formula and milk products growth in Australia and China. US profitability had also been extended.
The company planned to give firmer guidance for 2017 at its annual meeting in November, he said.
